Skip to main content
James Palazzolo, MD, Internal Medicine, Albany, GA

JamesVincentPalazzoloMD

Internal Medicine Albany, GA

Critical Care Medicine, Hospital Medicine/Hospitalist

Physician

Dr. Palazzolo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Palazzolo's full profile

Already have an account?

  • Office

    521 W 3rd Ave
    Albany, GA 31701
    Phone+1 229-438-5864
    Fax+1 229-439-4769

Education & Training

  • George Washington University
    George Washington UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 1990 - 1993
  • Corewell Health East Beaumont (Dearborn)
    Corewell Health East Beaumont (Dearborn)Residency, Internal Medicine, 1987 - 1990
  • St. George's University School of Medicine
    St. George's University School of MedicineClass of 1986

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2013 - 2026
  • GA State Medical License
    GA State Medical License 1993 - 2025
  • MI State Medical License
    MI State Medical License 1989 - 2025
  • DC State Medical License
    DC State Medical License 1990 - 2014

Publications & Presentations

PubMed

Press Mentions

  • Aerpio Pharmaceuticals, Inc. And Quantum Leap Healthcare Collaborative Announce the Selection of Razuprotafib for Evaluation in the I-SPY COVID Trial for the Treatment of Acute Respiratory Distress Syndrome in COVID-19 Patients
    Aerpio Pharmaceuticals, Inc. And Quantum Leap Healthcare Collaborative Announce the Selection of Razuprotafib for Evaluation in the I-SPY COVID Trial for the Treatment of Acute Respiratory Distress Syndrome in COVID-19 PatientsMay 26th, 2020
  • Quantum Leap Healthcare's I-SPY 2 Investigators, ARDS Experts and COVID R&D Consortium Unite to Bring Success from the I-SPY Adaptive Platform Clinical Trial to COVID-19 ARDS ICU Patients
    Quantum Leap Healthcare's I-SPY 2 Investigators, ARDS Experts and COVID R&D Consortium Unite to Bring Success from the I-SPY Adaptive Platform Clinical Trial to COVID-19 ARDS ICU PatientsApril 28th, 2020